We are hiring an innovative Chief Growth Officer to drive a step-change increase in Evidence Action’s impact. This full-time role reports to the CEO.
This is a rare moment to join a high-impact organization at an inflection point. While much of the global health sector has retracted since 2025, Evidence Action has strengthened its position — receiving increased support in 2025, participating in a new collaborative fund structure to accelerate the growth of one of our most promising programs, and heading into 2027 anticipating tailwinds for cost-effective giving. Over the past two years we have been professionalizing our fundraising function with real results: we are on track to more than triple our number of new high-net-worth individual supporters and expand our institutional partnerships year over year. The CGO who joins now will shape the function, the strategy, and the story — at precisely the moment the market is moving in our direction — all for the purpose of preventing deaths we already know how to solve.
You will oversee fundraising, communications and thought leadership across retail and major individual donors, strategic foundations, and institutions, in close partnership with our programmatic and operations teams. You will develop fundraising theses and collaborative funds for both new and growing programs and ensure all strategies and resources are appropriately aligned. Since 2017 we have raised $230M+ from GiveWell and have roughly doubled our other sources of funding — and we are on track to raise $60M this fiscal year a strong base from which your team — a strong base from which your team will drive the next order of magnitude of growth.
The ideal candidate is a proven closer with a strong track record of personally cultivating and closing seven-to-eight-figure relationships, has deep analytical instincts, and the ability to build and develop a high-performing team. The strongest candidates will come from major gifts and/or private institutional fundraising. We are also open to exceptional candidates from the private sector whose growth or business development work was relationship-driven and involved sophisticated, analytical counterparts — particularly from tech or finance. What matters most is a demonstrated ability to build trust through sustained cultivation and stewardship, a data-informed approach to pipeline development, and genuine excitement about making the case for cost-effective global health.